Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: ...

Here are five healthcare themes to watch next year, and which stocks stand to benefit. Key names to watch include Eli Lilly, ...

Health‑advertising researcher Erin Willis at the University of Colorado-Boulder said consumers are now bombarded with GLP-1 ...

The U.S. Food and Drug Administration has approved Novo Nordisk’s Wegovy® pill, making it the first and only oral GLP-1 ...

Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

With generic rivals waiting in the wings, Eli Lilly and Novo Nordisk are intensifying efforts to lock in market share in India’s rapidly expanding obesity drug market, turning pricing, promotion, and ...

Dedehouanou, H. (2025) Assessment of Potential Measures Aimed at Improving Graduates’ Employability at the University of Abomey-Calavi in Benin. Creative Education, 16, 2186-2209. doi: 10.4236/ce.2025 ...

Queen Latifah recently showcased a notable weight loss during a Disneyland outing with longtime partner Eboni Nichols.

Omeros (OMER) receives FDA approval for Yartemlea (narsoplimab) in TA-TMA, driving shares up nearly 80% to a $1bn+ valuation.

Novo Nordisk's Wegovy pill is the first oral GLP-1 receptor agonist approved for weight management, offering a new treatment ...